Biomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancer

doi:10.3748/wjg.v22.i2.887

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9199)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

719

WORD

399

HTML

4820

Figures (1-2)

351

Tables (1-2)

281

Sum=6570

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1043

Download

1586

Sum=2629

Jan 14, 2016 (publication date) through Feb 24, 2025

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Jan 14, 2016; 22(2): 887-894
Published online Jan 14, 2016. doi: 10.3748/wjg.v22.i2.887

Full Size Figure Download Figure

Figure 2 Schema of EVEREST II trial (a non-randomized phase II study). FOLFIRI: 5-fluorouracil/leucovorin/irinotecan.

Citation: Kubo A, Hashimoto H, Takahashi N, Yamada Y. Biomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancer. World J Gastroenterol 2016; 22(2): 887-894
URL: https://www.wjgnet.com/1007-9327/full/v22/i2/887.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i2.887